Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1950 2
1951 1
1953 2
1955 1
1956 2
1957 4
1958 1
1959 1
1960 15
1961 7
1962 9
1963 9
1964 7
1965 15
1966 13
1967 11
1968 10
1969 11
1970 12
1971 10
1972 8
1973 25
1974 14
1975 24
1976 20
1977 18
1978 19
1979 21
1980 27
1981 25
1982 24
1983 22
1984 18
1985 20
1986 29
1987 30
1988 62
1989 71
1990 76
1991 70
1992 96
1993 83
1994 82
1995 80
1996 83
1997 104
1998 101
1999 124
2000 149
2001 145
2002 158
2003 142
2004 182
2005 194
2006 180
2007 219
2008 224
2009 238
2010 265
2011 266
2012 289
2013 341
2014 369
2015 430
2016 514
2017 554
2018 616
2019 667
2020 810
2021 938
2022 1053
2023 947
2024 388

Text availability

Article attribute

Article type

Publication date

Search Results

10,467 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Sedayevatan
Page 1
Luca Saba.
[No authors listed] [No authors listed] Lancet Neurol. 2019 Jun;18(6):527. doi: 10.1016/S1474-4422(19)30114-0. Lancet Neurol. 2019. PMID: 31122492 No abstract available.
Response.
Wand O, Guber E, Guber A, Epstein Shochet G, Israeli-Shani L, Shitrit D. Wand O, et al. Chest. 2019 Apr;155(4):876-877. doi: 10.1016/j.chest.2019.01.020. Chest. 2019. PMID: 30955576 No abstract available.
Symbicort® Maintenance and Reliever Therapy (SMART) and the evolution of asthma management within the GINA guidelines.
Lin J, Zhou X, Wang C, Liu C, Cai S, Huang M. Lin J, et al. Expert Rev Respir Med. 2018 Mar;12(3):191-202. doi: 10.1080/17476348.2018.1429921. Epub 2018 Feb 5. Expert Rev Respir Med. 2018. PMID: 29400090 Review.
Expert commentary: SMART provides greater or equal levels of sustained asthma control than similar or higher fixed doses of ICS/LABA plus short-acting beta(2)-agonist (SABA) as needed or higher ICS plus SABA as needed, with lower overall ICS doses and cost. ...Budes …
Expert commentary: SMART provides greater or equal levels of sustained asthma control than similar or higher fixed doses of ICS/LABA plus sh …
Response.
Wand O, Guber E, Guber A, Epstein Shochet G, Israeli-Shani L, Shitrit D. Wand O, et al. Chest. 2019 Jun;155(6):1304. doi: 10.1016/j.chest.2019.02.013. Chest. 2019. PMID: 31174645 No abstract available.
Safety of SABA Monotherapy in Asthma Management: a Systematic Review and Meta-analysis.
Sriprasart T, Waterer G, Garcia G, Rubin A, Andrade MAL, Roguska A, Phansalkar A, Fulmali S, Martin A, Mittal L, Aggarwal B, Levy G. Sriprasart T, et al. Adv Ther. 2023 Jan;40(1):133-158. doi: 10.1007/s12325-022-02356-2. Epub 2022 Nov 8. Adv Ther. 2023. PMID: 36348141 Free PMC article. Review.
A random-effects model estimated rates of mortality, serious AEs (SAEs), and discontinuation due to AEs (DAEs) for as-needed and fixed-dose SABA treatment groups. ICS monotherapy and SABA therapy were compared using a fixed-effects model. ...SAE risk was comparable …
A random-effects model estimated rates of mortality, serious AEs (SAEs), and discontinuation due to AEs (DAEs) for as-needed and fixed-dose …
Landscape of short-acting beta-agonists (SABA) overuse in Europe.
de Las Vecillas L, Quirce S. de Las Vecillas L, et al. Clin Exp Allergy. 2023 Feb;53(2):132-144. doi: 10.1111/cea.14250. Epub 2022 Dec 5. Clin Exp Allergy. 2023. PMID: 36468654 Review.
Almost a third of European patients with asthma, at all severity levels, overuse SABA. Guidelines recommend close monitoring of patients who overuse SABA and avoiding over-reliance on SABA monotherapy. ...Changes in physician and patient behaviours towards …
Almost a third of European patients with asthma, at all severity levels, overuse SABA. Guidelines recommend close monitoring of patie …
Overuse of short-acting β2-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme.
Nwaru BI, Ekström M, Hasvold P, Wiklund F, Telg G, Janson C. Nwaru BI, et al. Eur Respir J. 2020 Apr 16;55(4):1901872. doi: 10.1183/13993003.01872-2019. Print 2020 Apr. Eur Respir J. 2020. PMID: 31949111 Free PMC article.
SABA use was grouped into 3-5, 6-10 and 11 canisters per baseline-year. ...CONCLUSION: One-third of asthma patients in Sweden collected three or more SABA canisters annually. SABA overuse was associated with increased risks of exacerbation and mortality. ...
SABA use was grouped into 3-5, 6-10 and 11 canisters per baseline-year. ...CONCLUSION: One-third of asthma patients in Sweden collect …
Expert Consensus on SABA Use for Asthma Clinical Decision-Making: A Delphi Approach.
Lugogo N, O'Connor M, George M, Merchant R, Bensch G, Portnoy J, Oppenheimer J, Castro M. Lugogo N, et al. Curr Allergy Asthma Rep. 2023 Nov;23(11):621-634. doi: 10.1007/s11882-023-01111-z. Epub 2023 Nov 22. Curr Allergy Asthma Rep. 2023. PMID: 37991672 Free PMC article. Review.
RECENT FINDINGS: In Phase 1 (n = 100 clinicians), 12% routinely provided patients with 4 SABA prescriptions/year, 73% solicited SABA use frequency at every patient visit, and 21% did not consult asthma guidelines/expert reports. Phase 3 experts (n = 8) reached conse …
RECENT FINDINGS: In Phase 1 (n = 100 clinicians), 12% routinely provided patients with 4 SABA prescriptions/year, 73% solicited SA …
Clarifying SABA overuse: Translating Canadian Thoracic Society guidelines into clinical practice.
Ellis AK, Foran V, Kaplan A, Mitchell PD. Ellis AK, et al. Allergy Asthma Clin Immunol. 2022 Jun 11;18(1):48. doi: 10.1186/s13223-022-00690-2. Allergy Asthma Clin Immunol. 2022. PMID: 35690850 Free PMC article.
SABA overuse is also associated with an increased risk of mortality. ...If the patient indicates use of > 2 SABA canisters per year or > 2 administrations of SABA per week for any reason, the patient does not have controlled asthma and PRN SABA i …
SABA overuse is also associated with an increased risk of mortality. ...If the patient indicates use of > 2 SABA canisters …
Helicobacter pylori BabA-SabA Key Roles in the Adherence Phase: The Synergic Mechanism for Successful Colonization and Disease Development.
Doohan D, Rezkitha YAA, Waskito LA, Yamaoka Y, Miftahussurur M. Doohan D, et al. Toxins (Basel). 2021 Jul 13;13(7):485. doi: 10.3390/toxins13070485. Toxins (Basel). 2021. PMID: 34357957 Free PMC article. Review.
The blood group antigen-binding adhesion (BabA) and sialic acid-binding adherence (SabA) are two H. pylori outer membrane proteins able to interact with antigens in the gastroduodenal tract. ...The adherence mechanisms of BabA and SabA allow H. pylori to anchor in t …
The blood group antigen-binding adhesion (BabA) and sialic acid-binding adherence (SabA) are two H. pylori outer membrane proteins ab …
10,467 results
You have reached the last available page of results. Please see the User Guide for more information.